advertisement

Topcon

Ahmed IIK 9

Showing records 1 to 9 | Display all abstracts from Ahmed IIK

112961 Preservative-Free versus Benzalkonium Chloride-Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial
Bacharach J
Clinical Ophthalmology 2023; 17: 2575-2588
112662 Surgical Augmentation of the Suprachoroidal Space: A Novel Material and Implant
De Francesco T; De Francesco T
Clinical Ophthalmology 2023; 17: 2483-2492
112926 Corneal Endothelial Safety Profile in Minimally Invasive Glaucoma Surgery
Ahmed IIK
Journal of Cataract and Refractive Surgery 2024; 50: 369-377
112961 Preservative-Free versus Benzalkonium Chloride-Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial
Ahmed IIK
Clinical Ophthalmology 2023; 17: 2575-2588
112926 Corneal Endothelial Safety Profile in Minimally Invasive Glaucoma Surgery
Sheybani A
Journal of Cataract and Refractive Surgery 2024; 50: 369-377
112662 Surgical Augmentation of the Suprachoroidal Space: A Novel Material and Implant
Ahmed IIK
Clinical Ophthalmology 2023; 17: 2483-2492
112961 Preservative-Free versus Benzalkonium Chloride-Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial
Sharpe ED
Clinical Ophthalmology 2023; 17: 2575-2588
112926 Corneal Endothelial Safety Profile in Minimally Invasive Glaucoma Surgery
De Francesco T; De Francesco T; Samuelson TW
Journal of Cataract and Refractive Surgery 2024; 50: 369-377
112961 Preservative-Free versus Benzalkonium Chloride-Preserved Latanoprost Ophthalmic Solution in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Phase 3 US Clinical Trial
Korenfeld MS; Zhang S; Baudouin C
Clinical Ophthalmology 2023; 17: 2575-2588

Issue 24-3

Change Issue


advertisement

Nidek